Interim FDG-PET Has No Value in Selecting Patients Who Require Treatment Modification in Both Early- And Advanced-Stage Hodgkin Lymphoma
British Journal of Haematology - United Kingdom
doi 10.1111/bjh.14906
Full Text
Open PDFAbstract
Available in full text
Categories
Date
September 14, 2017
Authors
Publisher
Wiley